University of Kansas Hospital Authority

academic medical center

Based in KS

🤖

AI Overview

With $950K in lobbying spend across 32 quarterly filings, University of Kansas Hospital Authority is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2025.

$950K
Total Spend
8
Years Active
1
Firms Hired
6
Lobbyists Deployed
4
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$110K
2019$120K
2020$120K
2021$120K
2022$120K
2023$120K
2024$120K
2025$120K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Telecommunications, Medicare/Medicaid

  • "Hospital Payment Reform/Site Neutral
  • "Hospital DSH Payments
  • "340B Drug Pricing Program
  • "H.R. 4392, a bill to prevent implementation of the 340B payment provision in the hospital OPPS rule.
  • "S.2312 -
  • "H.J. Res. 125- Making an extension of continuing appropriations for fiscal year 2018, and for other purposes
  • "Public Law No: 115-120 (H.R. 195) - Making further continuing appropriations for the fisc
  • 340B Drug Pricing issues
  • H.R. 4392, a bill to prevent implementation of the 340B payment provision in the hospital OPPS rule.
  • S.2312 - HELP Act
  • Liver Transplant Proposals
  • Kidney Dialysis and Transpla
  • H.Con.Res.71- Establishing the congressional budget for the United States Government for fiscal year 2018 and setting forth the appropriate budgetary levels for fiscal years 2019 through 2027.
  • S. 3158
  • H.R. 6470/S. 3158 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
  • H.R. 6157 [P.L. No: 115-952] - Department of Defense and Labor, Healt

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.